Literature DB >> 21663966

Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis.

Charlene Supnet1, Ilya Bezprozvanny.   

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disorder worldwide and is at present, incurable. The accumulation of toxic amyloid-beta (Aβ) peptide aggregates in AD brain is thought to trigger the extensive synaptic loss and neurodegeneration linked to cognitive decline, an idea that underlies the 'amyloid hypothesis' of AD etiology in both the familal (FAD) and sporadic forms of the disease. Genetic mutations causing FAD also result in the dysregulation of neuronal calcium (Ca(2+)) handling and may contribute to AD pathogenesis, an idea termed the 'calcium hypothesis' of AD. Mutations in presenilin proteins account for the majority of FAD cases. Presenilins function as catalytic subunits of γ-secretase involved in the generation of Aβ peptide. Recently, we discovered that presenilns function as low-conductance, passive ER Ca(2+) leak channels, independent of γ-secretase activity. We further discovered that many FAD mutations in presenilins results in the loss of ER Ca(2+) leak function activity and Ca(2+) overload in the ER. These results provided potential explanation for abnormal Ca(2+) signaling observed in FAD cells with mutations in presenilns. The implications of these findings for understanding AD pathogenesis are discussed in this article.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21663966      PMCID: PMC3172403          DOI: 10.1016/j.ceca.2011.05.013

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  91 in total

1.  Calcium, membranes, aging, and Alzheimer's disease. Introduction and overview.

Authors:  Z S Khachaturian
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

2.  Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.

Authors:  Grace E Stutzmann; Ian Smith; Antonella Caccamo; Salvatore Oddo; Frank M Laferla; Ian Parker
Journal:  J Neurosci       Date:  2006-05-10       Impact factor: 6.167

Review 3.  Calcium homeostasis and modulation of synaptic plasticity in the aged brain.

Authors:  Thomas C Foster
Journal:  Aging Cell       Date:  2007-06       Impact factor: 9.304

Review 4.  The amyloid hypothesis for Alzheimer's disease: a critical reappraisal.

Authors:  John Hardy
Journal:  J Neurochem       Date:  2009-05-18       Impact factor: 5.372

5.  Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins.

Authors:  B De Strooper; M Beullens; B Contreras; L Levesque; K Craessaerts; B Cordell; D Moechars; M Bollen; P Fraser; P S George-Hyslop; F Van Leuven
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

Review 6.  Calcium signaling and amyloid toxicity in Alzheimer disease.

Authors:  Angelo Demuro; Ian Parker; Grace E Stutzmann
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

7.  A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis.

Authors:  Suzuka Ataka; Takami Tomiyama; Hiroshi Takuma; Takenari Yamashita; Hiroyuki Shimada; Tsuyoshi Tsutada; Koichi Kawabata; Hiroshi Mori; Takami Miki
Journal:  Arch Neurol       Date:  2004-11

Review 8.  Presenilin: RIP and beyond.

Authors:  Matthew R Hass; Chihiro Sato; Raphael Kopan; Guojun Zhao
Journal:  Semin Cell Dev Biol       Date:  2008-11-27       Impact factor: 7.727

9.  Deviant ryanodine receptor-mediated calcium release resets synaptic homeostasis in presymptomatic 3xTg-AD mice.

Authors:  Shreaya Chakroborty; Ivan Goussakov; Megan B Miller; Grace E Stutzmann
Journal:  J Neurosci       Date:  2009-07-29       Impact factor: 6.167

10.  Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons.

Authors:  W G Annaert; L Levesque; K Craessaerts; I Dierinck; G Snellings; D Westaway; P S George-Hyslop; B Cordell; P Fraser; B De Strooper
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

View more
  32 in total

1.  Presenilin-like GxGD membrane proteases have dual roles as proteolytic enzymes and ion channels.

Authors:  Ivana Y Kuo; Jian Hu; Ya Ha; Barbara E Ehrlich
Journal:  J Biol Chem       Date:  2015-01-21       Impact factor: 5.157

Review 2.  Calcium's role as nuanced modulator of cellular physiology in the brain.

Authors:  Hilaree N Frazier; Shaniya Maimaiti; Katie L Anderson; Lawrence D Brewer; John C Gant; Nada M Porter; Olivier Thibault
Journal:  Biochem Biophys Res Commun       Date:  2016-08-20       Impact factor: 3.575

3.  Schisandrin ameliorates cognitive impairment and attenuates Aβ deposition in APP/PS1 transgenic mice: involvement of adjusting neurotransmitters and their metabolite changes in the brain.

Authors:  Bin-Bin Wei; Ming-Yan Liu; Zai-Xing Chen; Min-Jie Wei
Journal:  Acta Pharmacol Sin       Date:  2018-01-11       Impact factor: 6.150

Review 4.  Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime.

Authors:  MaryKate McBrayer; Ralph A Nixon
Journal:  Biochem Soc Trans       Date:  2013-12       Impact factor: 5.407

Review 5.  Dantrolene, a treatment for Alzheimer disease?

Authors:  Li Liang; Huafeng Wei
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jan-Mar       Impact factor: 2.703

Review 6.  ApoE, ApoE Receptors, and the Synapse in Alzheimer's Disease.

Authors:  Courtney Lane-Donovan; Joachim Herz
Journal:  Trends Endocrinol Metab       Date:  2017-01-02       Impact factor: 12.015

Review 7.  β-Secretase: its biology as a therapeutic target in diseases.

Authors:  Haibo Wang; Rena Li; Yong Shen
Journal:  Trends Pharmacol Sci       Date:  2013-02-27       Impact factor: 14.819

Review 8.  FK506-binding protein 1b/12.6: a key to aging-related hippocampal Ca2+ dysregulation?

Authors:  J C Gant; E M Blalock; K-C Chen; I Kadish; N M Porter; C M Norris; O Thibault; P W Landfield
Journal:  Eur J Pharmacol       Date:  2013-11-28       Impact factor: 4.432

Review 9.  Activation of PARP by oxidative stress induced by β-amyloid: implications for Alzheimer's disease.

Authors:  Rosella Abeti; Michael R Duchen
Journal:  Neurochem Res       Date:  2012-10-18       Impact factor: 3.996

10.  β amyloid peptide plaques fail to alter evoked neuronal calcium signals in APP/PS1 Alzheimer's disease mice.

Authors:  Clark A Briggs; Corinne Schneider; Jill C Richardson; Grace E Stutzmann
Journal:  Neurobiol Aging       Date:  2013-01-18       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.